Zura Bio Limited (ZURA)
NASDAQ: ZURA · Real-Time Price · USD
1.235
+0.085 (7.39%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Zura Bio Employees
Zura Bio had 30 employees as of December 31, 2024. The number of employees increased by 15 or 100.00% compared to the previous year.
Employees
30
Change (1Y)
15
Growth (1Y)
100.00%
Revenue / Employee
n/a
Profits / Employee
-$1,512,867
Market Cap
84.10M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 30 | 15 | 100.00% |
| Dec 31, 2023 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
ZURA News
- 24 days ago - Zura Bio Reports Full Year 2024 Financial Results and Recent Corporate Updates - Business Wire
- 7 weeks ago - Zura Bio to Present at the Leerink Partners Global Healthcare Conference - Business Wire
- 4 months ago - Zura Bio Launches Global Phase 2 TibuSURE Study to Evaluate Tibulizumab in Adults With Systemic Sclerosis - Business Wire
- 5 months ago - Zura Bio to Present at the Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 5 months ago - Zura Bio Announces Submission of Protocol to U.S. Food and Drug Administration for the Phase 2 Study of Tibulizumab in Adults with Systemic Sclerosis - Business Wire
- 5 months ago - Zura Bio Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - Business Wire
- 6 months ago - Zura Bio to Participate in Two Upcoming Investor Conferences in November - Business Wire
- 8 months ago - CPS HR Consulting Partners with GovInvest to Revolutionize Compensation Consulting with Advanced Technology - Business Wire